The University of Texas MD Anderson Cancer Center again supports World Cancer Research Day, Sept. 24, and its goals to spotlight the importance of cancer research, to advertise scientific collaboration and to cut back the worldwide burden of cancer through improved prevention, early detection, treatment and survivorship strategies.
Launched in 2016, World Cancer Research Day is a world effort now supported by greater than 120 organizations to boost awareness and encourage collaboration. This 12 months’s theme, “Support Research to Prevent Cancer and Catch it Early,” focuses on the importance of cancer prevention, addressing health disparities and advocating for access to effective screening and early detection practices for all communities.
MD Anderson is home to one in every of the most important and most developed cancer prevention programs within the nation, and its experts lead research and education efforts that aid communities by helping them develop healthy lifestyle decisions and by providing early detection screening that may significantly reduce the danger of cancer or catch it at its earliest stages. Through a multidisciplinary approach, the institution works to eliminate health disparities in cancer and to translate research discoveries into clinical advances using evidence-based detection and prevention strategies.
Considered one of many examples is MD Anderson’s Pre-Cancer Atlas project, which is led by teams of researchers to generate a comprehensive biological roadmap of pre-cancer development to be able to discover avenues for cancer interception. By gaining a greater understanding of the trail from pre-cancer to cancer, researchers hope to design strategies to intervene before cells turn into malignant.
“The present focus of World Cancer Research Day aligns with our own mission, as we recognize the tremendous impact of evidence-based prevention and early detection research and techniques,” said Giulio Draetta, M.D., Ph.D., chief scientific officer. “Research is key to the whole lot we do at MD Anderson, and we’re proud to have a few of one of the best minds on this planet working collaboratively to advance breakthroughs across the spectrum of cancer science to be able to improve the lives of the patients and communities we serve.”
For greater than 80 years, MD Anderson has focused on creating integrated and comprehensive programs that allow scientists to advance impactful discovery, prevention, and translational and clinical research that may provide meaningful advantages to patients. Last fiscal 12 months alone, the institution invested greater than $1.03 billion in research and led the nation in cancer research funding through the National Institutes of Health.
The unique ability of scientists and physicians to seamlessly collaborate and share insights in an ongoing cycle of innovation, is an indicator of what makes the environment at MD Anderson exceptionally suited to drive breakthroughs at an unmatched pace.
Findings from the lab could be rapidly translated to the clinic by leveraging established research platforms and programs, comparable to the institution’s Therapeutics Discovery division, which accelerates the invention and development of life-saving medicines. MD Anderson leads one in every of the most important clinical trials programs on this planet, with greater than 1,300 currently energetic clinical trials, to guage novel drugs, diagnostics and treatment strategies. Within the previous fiscal 12 months, the institution was awarded nearly 200 patents and its researchers contributed work for 29 drugs that received FDA approval.
Within the spirit of collaborative progress, MD Anderson is also proud to host the upcoming Leading Fringe of Cancer Research Symposium from Nov. 17-18. Open to all researchers, the virtual event is a chance to facilitate discussions on vital and emerging topics in the sphere. The symposium features presentations on therapeutic strategies and clinical data science in addition to a panel discussion on patient-focused research and high-value cancer care.
Source:
University of Texas MD Anderson Cancer Center